Literature DB >> 433019

Bone pain in metastatic cancer of prostate.

J J Pollen, J D Schmidt.   

Abstract

The characteristics of bone pain in metastatic cancer of the prostate were studied in 23 patients. The pain may be continuous or intermittent, show diurnal variations, and be migratory. The effects of activity, rest, and alcohol vary in different individuals. Relief of bone pain by analgesic medications is unsatisfactory. Aspirin-containing compounds are often more effective than narcotics for pain relief. The effects of external beam irradiation for palliation of pain are unpredictable.

Entities:  

Mesh：

Year:  1979        PMID： 433019     DOI： 10.1016/0090-4295(79)90280-2

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  6 in total

1.  [Not Available].

Authors:  I Kiss
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

2.  Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.

Authors:  W Y Lin; C P Lin; S J Yeh; B T Hsieh; Z T Tsai; G Ting; T C Yen; S J Wang; F F Knapp; M G Stabin
Journal:  Eur J Nucl Med       Date:  1997-06

3.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

4.  [Brain tumor and headache.].

Authors:  I Kiss; M Franz; M Kilian
Journal:  Schmerz       Date:  1994-09       Impact factor: 1.107

5.  Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience.

Authors:  C Münger-Beyeler; J Bernhard; K Rufibach; R Morant; H-P Schmid
Journal:  Support Care Cancer       Date:  2007-10-02       Impact factor: 3.603

Review 6.  AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions.

Authors:  Judith A Paice; Matt Mulvey; Michael Bennett; Patrick M Dougherty; John T Farrar; Patrick W Mantyh; Christine Miaskowski; Brian Schmidt; Thomas J Smith
Journal:  J Pain       Date:  2016-11-21       Impact factor: 5.820
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.